EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS135-01623 
Organism
Homo sapiens 
Tissue/cell
MM1S 
Coordinate
chr22:22521320-22523300 
TF binding sites/motifs
Number: 9             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOXP1MA0481.2chr22:22523177-22523189AGGTAAACAGAA+6.14
IRF1MA0050.2chr22:22522714-22522735TGTCTGTTTCGGTTTCAGTAT+6.12
IRF8MA0652.1chr22:22522718-22522732TGTTTCGGTTTCAG-6.51
IRF9MA0653.1chr22:22522718-22522733TGTTTCGGTTTCAGT-6.28
MLXMA0663.1chr22:22523099-22523109ATCACGTGAT+6.02
MLXMA0663.1chr22:22523099-22523109ATCACGTGAT-6.02
MLXIPLMA0664.1chr22:22523099-22523109ATCACGTGAT+6.02
MLXIPLMA0664.1chr22:22523099-22523109ATCACGTGAT-6.02
NKX2-5MA0063.2chr22:22522367-22522377CTCAAGTGGT-6.02
Number of super-enhancer constituents: 4             
IDCoordinateTissue/cell
SE_10412chr22:22515989-22524255CD19_Primary
SE_11755chr22:22515924-22526610CD20
SE_43941chr22:22519587-22524246MM1S
SE_58581chr22:22508304-22574865Ly1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr222252140022521863
Number: 1             
IDChromosomeStartEnd
GH22I022165chr222251942722523670
Enhancer Sequence
GAATTTCAGC CCCCATCCCC AGCAATGAGT TGAATGAAAT GGTACAAGGC AGAGCACACC 60
AGCCCTCAGT ATTCCCTCCC TGAACCCAGA CTCTGGTGGT TATGGGGGCC AGGGAGGACC 120
AGAGCTTTGT CTCCCACCTG GCAATGAGAA TACTGGTTGG GGATGGAAGT CAGTGTCGTT 180
GGCACACCTG CTGTCCCCCT CCCTGCCCTG GTGTCAGTGA GTCCTCTTTT TCTCATGAAA 240
GTGTCAGCAG CACTGGAGTA CTGAGAGCCA GCGTTCTGCC TTTGCTTTGG CAGTGGGAAG 300
CTGAACCTAC AAACCTGTGT CCTTCAACAA CTCAACAAGA AGATCACCTG ATAAAAGGGA 360
GATTAGTGGT GCCTAGAGGC TCAAAATACA GTATTTAAGG TGTCTAGCAT TCAGTTCATG 420
AAATCATTGT CACATCAAGA ATTAGGACAT TCAGAACCCA AATGAAAGAA GACAGTGACA 480
CGCATGGACA CTGAAGCAAA CTCAGATGCT AAAATCATAT GACGGATTTT TAAAGCAACA 540
ACCACAAAAT CCCTTCAATG AATAATTAAA AACACTCTTG AAACAAATGG AAAAGAAGAA 600
AATCTCAGAA AAGAGAAGTT ATAAAATCAA ACCAACTGGA AATTAAAGAA CCTAATAAAC 660
TAGAGCACAT TTAAAAAGAA AGTTAAGGCA GGACTCAAGA ACTGGTTACA TTTGAGATTC 720
AGTCACTGGG TGAGGTGTTC CACACGACAT AAAAATACAG TAAAAATAAG TAGGTAAACA 780
CATGAAAATC AATGATTCTG GTTTGACTTG GGAAACATTA AAGTGGAAAA TATAAAGAAT 840
AAAATAGCAT TTATTTATTG AAAGAAAGAA CTACCTTTAG CTTTTTATCG TTTCCCCATT 900
AATACTCTCT TGAAGATGTT CCCAGGGGAC ACTGTGAGTC TTCTCAGAGG TGAGAAAAGC 960
CTGAAATAAA CTCCCACGAA TCTCATTTAA TGGGTCCTGG GGCCCATGCT CACTGGTCTG 1020
AGTTAGAGGT GATAGCAGGT GCTTCCTCTC AAGTGGTGAA ATTAGACCTC ACAGCAGCCC 1080
AGCCCCCCTG ACAGTAGAGC TGCTCTCTCA GCTGAAAACA ACAGAAGCAG ATGGTGTTGG 1140
TGATGGTTTT GGTAAAGTGC TTATTAATGT GTGAACCAAA TATATGCCCT TCATCTAGGG 1200
AGCTGCATAG GAGATAAAAG AACCATCTCA GGGTCCAGCA GCATCTTAGA GCTCTGCAGA 1260
TTTTTGGAAA GTTTACATCA TGCCCTGGAT GCTTCTCCTC CACTTCCCCA TCCTGTTCAG 1320
TCTTTGCCCA GGTTCATGGA GATTTCAAAG ACCAGCCCAT GGAGAGAGCC CTCTGTTCTT 1380
CCCCATTCCT GTCGTGTCTG TTTCGGTTTC AGTATCCAGT TCTTAGGGTG TGGTGACTGA 1440
GGAGCCCTCA CTGACTCTTT CCTGAGGAGG GACAGTCACT CTCACCTGTG GCTCCAGCAC 1500
CAGAGTGGTC ACCAACAATT TCTATCCACA CTGGATGCAA CAGAAGTCTG GCCAACTTTT 1560
TGAGACATTG ATTTATGATG CAAGCAACAA ACATTCCTGA ATGACCACCT GATTCTCAGA 1620
CCTTCCTGGG AGCAAAGCTG CCCTGAGCCT CTGGGGGACC CAATCCATAG GCTAGACTGA 1680
GTACTACTCA AGCTACACGA CAGTGGGGGT TACTGCAGTG AAAGATCCAG ATGGGGAGCC 1740
AAGACGTAAC CCTGCCTCTG ACAGCCTGGG GAGAAAATGA TCACGTGATA TCAGGATCAC 1800
ATGACCAGAA ACCTGAGCTC TCAAGGCGGT CTAAATGTTG CCTATCCTTA AAGAAAAAGG 1860
TAAACAGAAG GGTCTACATC AATATTTATT CCTGTTTGTG TCCAAAAGTT GAGGAAATCC 1920
ATCAATGAGG AGGAACTGTT CCAGAAAAGC GGATTCCTAA TATTTTGTAA TCCAAAAGGA 1980